Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Licensing opportunity from BTG: topically active 5-LO inhibitor for psoriasis

Oct. 21, 1998

Negotiations between Altana and Hyal for licensing Solarase terminated

Oct. 19, 1998

Access signs agreement for amlexanox distribution in four additional markets

Oct. 19, 1998

Successful completion of human safety trials reported for VIMRx wound-healing agent

Oct. 14, 1998

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

More data reported for ADCON-P; FDA okays pivotal trial

Oct. 14, 1998

Demegen's Peptidyl MIM compound D4B effectively treats infected wounds

Oct. 13, 1998

Xoma completes phase II enrollment in psoriasis study

Oct. 13, 1998

Bristol-Myers Squibb and Unilever enter collaborative agreement for hair loss research

Oct. 9, 1998

Nonpeptide BK antagonist effective in guinea pig models of allergy

Oct. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...